We celebrated 5,700 Scientific Articles in @PharmaceuticalIntelligence.com on November 20, 2019
Editor-in-Chief: Aviva Lev-Ari, PhD, RN
5,700 Articles
691 Categories
1,688,036 e-Readers
7,369 comments
The Digital Age Gave Rise to New Definitions – New Benchmarks were born on the World Wide Web for the Intangible Asset of Firm’s Reputation: Pay a Premium for buying e-Reputation
For the Journal Access:
https://wordpress.com/view/pharmaceuticalintelligence.com
For the BioMed e-Series Access:
https://wordpress.com/view/pharmaceuticalintelligence.com
For 70 Conference e-Proceedings Access:
Other links may be of interest:
- Executive Summary
- Opportunities Map in the Acquisition Arena
- Dynamic Contents for LPBI Group’s PowerPoint Presentation
- Detailed Technology Description
- Curation Methodology – Digital Communication Technology to mitigate Published Information Explosion and Obsolescence in Medicine and Life Sciences
- Top Authors by Number of eReaders Views
- Top Articles by Number of e-Readers for All Days ending 2019-02-17
- LPBI Group’s Social Media Presence
- Financial Valuation of Three Health Care Intellectual Property (IP) Content Asset Classes
- Global Market Penetration Forecast for each Volume in the 16 Volume BioMed e-Series
- Potential Use of LPBI IP as Value Price Driver by Potential Acquirer: Assumptions per Asset Class
- Financial Advisory & Legal Advisory Providers: US & Israel
- Founder’s Role in the Development of Venture’s Factors of Content Production – Biographical Notes by Aviva Lev-Ari, PhD, RN, LPBI Group
- FIT Members Contribute to Opportunities Map
- FINAL IMPROVEMENT TEAM (FIT): Definition of Active, Lapsing of Active Status, COMPs Formulas
- Mostly HONORED to be followed by [from an Excerpt of 117 Followers of the Twitter Account @AVIVA1950 from the List of 359 Followers] by the Number of their Followers on 2/24/2019
- LPBI Group is mostly HONORED to be followed by [from an Excerpt of 136 Followers of the Twitter Account @pharma_BI from the List of 505 Followers] by the Number of their Followers on 3/20/2019
- FIT members – Who works on WHAT?
- Comparative Analysis of the Level of Engagement for Four Twitter Accounts: @KDNuggets (Big Data) @GilPress @Forbes @pharma_BI @AVIVA1950
- MEDIA organizations as Followers of @pharma_BI the Official Twitter Account of LPBI Group (136 out of 505 Followers): Number of Followers’ Followers, Institutions (I) and Individuals (Persons(P)), RED = Mostly Honored to be followed by
- JOURNAL Statistics on 2/24/2019
- Excerpt of 136 Followers of @pharma_BI (from the List of 505 Followers) by the Number of their Followers on 3/20/2019
- Excerpt of 117 Followers of @AVIVA1950 (from the List of 359 Followers) by the Number of their Followers
- REACH – Two Handles on Twitter.com @AVIVA1950 @pharma_BI
- 2013-2019, On the Medical & Scientific Bookshelf in Kindle Store: eReader Behaviors: Browsing, Page Downloads and Buying e-Books – LPBI Group’s BioMed e-Series, Royalties Payment Analysis
- Connections First Level on LinkedIn: 500 CEOs, 200 Big Pharma Professionals, 7,000 in Total: LPBI Group Founder – Aviva Lev-Ari, PhD, RN
- Summer 2019 Plan – Research Associates Tasks
- LPBI’s Pipeline Map: A Positioning Perspectives – An Outlook to the Future from the Present
- WHAT ARE LPBI Group’s NEEDS in June 2019: Aviva’s BOLD VISION on June 11, 2019
- For @AVIVA1950, Founder, LPBI Group @pharma_BI: Twitter Analytics [Engagement Rate, Link Clicks, Retweets, Likes, Replies] & Tweet Highlights [Tweets, Impressions, Profile Visits, Mentions, New Followers] https://analytics.twitter.com/user/AVIVA1950/tweets
Leave a Reply